{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:53:25Z","timestamp":1781704405950,"version":"3.54.5"},"reference-count":19,"publisher":"Norwegian Medical Association","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.16.0657","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T08:28:45Z","timestamp":1507019325000},"source":"Crossref","is-referenced-by-count":0,"title":["Rosacea"],"prefix":"10.4045","volume":"137","author":[{"given":"Theis","family":"Huldt-Nystr\u00f8m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti","family":"Danielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina Zak","family":"Stangeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Tan\u00a0J, Berg\u00a0M. Rosacea: current state of epidemiology. J Am Acad Dermatol 2013; 69: S27\u201335. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24229634&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jaad.2013.04.043","DOI":"10.1016\/j.jaad.2013.04.043"},{"key":"ref=2","unstructured":"Moore\u00a0A, Kempers\u00a0S, Murakawa\u00a0G et al. Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study. J Drugs Dermatol 2014; 13: 56\u201361. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24385120&dopt=Abstract"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Wilkin\u00a0J, Dahl\u00a0M, Detmar\u00a0M et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46: 584\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11907512&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1067%2Fmjd.2002.120625","DOI":"10.1067\/mjd.2002.120625"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Abram\u00a0K, Silm\u00a0H, Maaroos\u00a0HI et al. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol 2010; 24: 565\u201371. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19874433&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1468-3083.2009.03472.x","DOI":"10.1111\/j.1468-3083.2009.03472.x"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Aldrich\u00a0N, Gerstenblith\u00a0M, Fu\u00a0P et al. Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins. JAMA Dermatol 2015; 151: 1213\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26307938&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Fjamadermatol.2015.2230","DOI":"10.1001\/jamadermatol.2015.2230"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Chang\u00a0AL, Raber\u00a0I, Xu\u00a0J et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol 2015; 135: 1548\u201355. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25695682&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fjid.2015.53","DOI":"10.1038\/jid.2015.53"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Steinhoff\u00a0M, Buddenkotte\u00a0J, Aubert\u00a0J et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 2011; 15: 2\u201311. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22076321&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fjidsymp.2011.7","DOI":"10.1038\/jidsymp.2011.7"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Feldman\u00a0SR, Huang\u00a0WW, Huynh\u00a0TT. Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease. J Manag Care Spec Pharm 2014; 20: 623\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24856600&dopt=Abstract","DOI":"10.18553\/jmcp.2014.20.6.623"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Picardo\u00a0M, Ottaviani\u00a0M. Skin microbiome and skin disease: the example of rosacea. J Clin Gastroenterol 2014; 48: S85\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25291137&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2FMCG.0000000000000241","DOI":"10.1097\/MCG.0000000000000241"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Schaller\u00a0M, Almeida\u00a0LM, Bewley\u00a0A et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol 2017; 176: 465\u201371. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27861741&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fbjd.15173","DOI":"10.1111\/bjd.15173"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"van Zuuren\u00a0EJ, Fedorowicz\u00a0Z. Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments. Br J Dermatol 2015; 173: 651\u201362. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26099423&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fbjd.13956","DOI":"10.1111\/bjd.13956"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Blom\u00a0I, Hornmark\u00a0AM. Topical treatment with sulfur 10 per cent for rosacea. Acta Derm Venereol 1984; 64: 358\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6209901&dopt=Abstract","DOI":"10.2340\/0001555564358359"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Dahl\u00a0MV, Katz\u00a0HI, Krueger\u00a0GG et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol 1998; 134: 679\u201383. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9645635&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Farchderm.134.6.679","DOI":"10.1001\/archderm.134.6.679"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Taieb\u00a0A, Ortonne\u00a0JP, Ruzicka\u00a0T et al. Superiority of ivermectin 1% cream over metronidazole 0\u00b775% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol 2015; 172: 1103\u201310. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25228137&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fbjd.13408","DOI":"10.1111\/bjd.13408"},{"key":"ref=15","unstructured":"Jackson\u00a0JM, Fowler\u00a0J, Moore\u00a0A et al. Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea. J Drugs Dermatol 2014; 13: 699\u2013704. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24918560&dopt=Abstract"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Jackson\u00a0JM, Knuckles\u00a0M, Minni\u00a0JP et al. The role of brimonidine tartrate gel in the treatment of rosacea. Clin Cosmet Investig Dermatol 2015; 8: 529\u201338. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26566370&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2147%2FCCID.S58920","DOI":"10.2147\/CCID.S58920"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Gollnick\u00a0H, Blume-Peytavi\u00a0U, Szab\u00f3\u00a0EL et al. Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 2010; 8: 505\u201315. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20337772&dopt=Abstract","DOI":"10.1111\/j.1610-0387.2010.07345.x"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Nymann\u00a0P, Hedelund\u00a0L, H\u00e4dersdal\u00a0M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol 2010; 24: 143\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20205349&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1468-3083.2009.03357.x","DOI":"10.1111\/j.1468-3083.2009.03357.x"},{"key":"ref=19","unstructured":"Del Rosso\u00a0JQ, Thiboutot\u00a0D, Gallo\u00a0R et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. Cutis 2014; 93: 134\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24738094&dopt=Abstract"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:01:27Z","timestamp":1781701287000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2017\/10\/klinisk-oversikt\/rosacea"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":19,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2017,10,3]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.16.0657","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]}}}